We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Canine Blood Biomarkers Indicate Septic Infection in Humans Too

By LabMedica International staff writers
Posted on 22 Dec 2011
The amount of certain blood biomarkers is a good indication of infection in dogs, and the same would hold true in humans suffering from similar conditions. More...


In pets and people, the time it takes to diagnose an infection may mean life or death, and identifying ways to diagnose pet infections in approximately a third of the current diagnosis time could be used eventually for humans.

Veterinarians at the University of Missouri (Columbia, MO, USA) tested several biomarkers for infection in dogs. They found that found that measuring the amount of the blood biomarker N-terminal portion of pro C-type natriuretic peptide (NT-pCNP) is a good indication of infection, and the same could be applied in humans. In one study, the NT-pCNP assay was performed by a sandwich enzyme-linked immunoassay (ELISA), (Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria). This ELISA utilizes a highly purified polyclonal sheep antibody directed against amino acids 1-19 and 30-50 of human NT-pCNP that is 96% homologous with canine pCNP.

In a separate study plasma samples obtained from both septic and normal control groups were used for determination of the nitric oxide end products nitrate (NO3–) and nitrite (NO2–) using a commercially available kit , the Parameter Total Nitric Oxide and Nitrite/Nitrate Assay; (R&D Systems, Minneapolis, MN, USA). This two-step assay utilizes nitrate reductase to convert nitrate to nitrite and then detects total nitrite using the Greiss reaction to produce an azo dye compound. The range of detection of this assay is 3.12-200 µmol/L.

Plasma total nitrate/nitrite was significantly greater in the sepsis group compared with the control group and a systemic inflammatory response syndrome (SIRS) group. Serum NT-pCNP concentration was significantly greater in the sepsis group (median, 11 pmol/L) compared with the noninfectious forms of SIRS (5.2 pmol/L); and healthy control groups (6.4 pmol/L). Amy DeClue, DVM, assistant professor of veterinary internal medicine, said, "My group has been evaluating different blood biomarkers that could give a quick and accurate indication of infection, and we believe we've found a biomarker that will only require a simple blood test. The systems in dogs and people are very applicable to each other, so whatever biomarkers we find in dogs could also benefit people."

The scientists hope to develop a portable bedside test that veterinarians could use to quickly test patients for infection and ultimately target a better cure. The NT-pCNP biomarker study was published in the May/June 2011 issue of Journal of Veterinary Internal Medicine and the plasma nitrate/nitrite study was published online on September 9, 2011, in the journal Veterinary Record.

Related Links:
University of Missouri
Biomedica Medizinprodukte
R&D Systems



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Automated Urinalysis Solution
UN-9000
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.